Ownership signal CIK-linked ownership evidence from parsed SEC filings. 2 signals
Large-stake signal

Form

SCHEDULE 13D/A

Active or control-oriented beneficial ownership filing.

Ownership

9.5%

Beneficial ownership of this reported class.

Shares

18,312,735 shares

Shares beneficially owned as disclosed.

Event date

01 Jan 2026

Date tied to the ownership event or amendment.

Accepted by SEC

09 Jan 2026

EDGAR acceptance date.

How to read this large-stake filing
  • Schedule 13D/G filings focus on beneficial ownership stakes, not a full portfolio.
  • Compare this filing with the holder history and issuer page before treating the percentage as a current position.
  • Use amendments to understand whether the disclosed stake increased, decreased, or changed reporting status.
Subject security Names, identifiers, and filing context for this profile. 2 source fields
Symbol
AHAC
Shares outstanding
192,765,632 shares
Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
SCHEDULE 13D/A
Accepted by SEC
09 Jan 2026, 11:42:54 UTC
Event date
01 Jan 2026
Prior SEC filing
16 Oct 2025
Source filing
View source filing

Key filing fact

Fresenius Medical Care AG disclosed 9.5% ownership in HUMACYTE, INC. Common Stock, par value $0.0001 per share (AHAC) on 01 Jan 2026.

Key facts

  • Fresenius Medical Care AG filed SCHEDULE 13D/A for HUMACYTE, INC. Common Stock, par value $0.0001 per share (AHAC).
  • Disclosed ownership: 9.5%.
  • Date of event: 01 Jan 2026.

Change

  • Previous schedule filing date: 16 Oct 2025.
  • Current filing was accepted on 09 Jan 2026, 11:42.

Research use

  • This page turns one Schedule 13D/G filing into a quick large-stake read before the raw reporting-person rows.
  • Use the linked SEC filing as the source of truth for ownership percentages, shares, and reporting-party details.

Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

View source filing

Reporting persons

Disclosed reporting parties (2)

Names, ownership percentages, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.

Name Ownership Shares owned Sole voting power Shared voting power Signature Title CIK
Fresenius Medical Care Holdings, Inc. 9.5% 18,312,735 0 18,312,735 /s/ Bryan Mello Bryan Mello, Assistant Treasurer 0000042872
Fresenius Medical Care AG 9.5% 18,312,735 0 18,312,735 /s/ Dr. Joerg Haering Dr. Joerg Haering, Member of the Management Board 0001333141
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .